Your browser doesn't support javascript.
An update from the Canadian Association for the Study of the Liver on the management of liver disease during the COVID-19 pandemic.
Brahmania, Mayur; Congly, Stephen; Jayakumar, Saumya; Coffin, Carla S; Burak, Kelly W; Feld, Jordan J.
  • Brahmania M; Department of Medicine, Western University, London, Ontario, Canada.
  • Congly S; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Jayakumar S; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Coffin CS; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Burak KW; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Feld JJ; Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, Ontario, Canada.
Can Liver J ; 3(4): 309-321, 2020.
Article in English | MEDLINE | ID: covidwho-958178
ABSTRACT
Coronavirus disease 2019 (COVID-19) has challenged how care is delivered to patients with chronic liver disease (CLD). In an attempt to update Canadian health care practitioners taking care of individuals with CLD, the Canadian Association for the Study of the Liver (CASL) hosted a webinar on May 7, 2020, with more than 120 participants. The resultant article is a partnership between members of CASL's executive and education committees to provide best practice management principles on liver disease during COVID-19 to the broader hepatology community.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Can Liver J Year: 2020 Document Type: Article Affiliation country: Canlivj-2020-0013

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Can Liver J Year: 2020 Document Type: Article Affiliation country: Canlivj-2020-0013